ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please be informed that Alembic Pharmaceuticals Limited received one USFDA product approval during the quarter ended 31st March, 2024. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Change in Directorate
Please find attached herewith the intimation for completion of tenure of the Independent Directors of the Company w.e.f. end of the day on 31st March. 2024. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Change in Directorate
The Board of Directors at its Meeting held today has approved the appointment of Mr. Manish Kejriwal (DIN: 00040055) as an Independent Director of the Company for a period of 5 consecutive years w.e.f. 31st March, 2024 subject to the approval of the Members by way of Special resolution proposed to be passed through Postal Ballot. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith a copy of newspaper advertisement related to Notice for Claiming of Shares from Company''s Unclaimed Suspense Account published in English language newspaper - Business Standard on 28th March, 2024. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached herewith the intimation dated 28th March, 2024 received from our RTA. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclose herewith the intimation dated 28th March, 2024 received from RTA, regarding approval of request received for Issue of Duplicate Share Certificate(s) and issue of Letter of Confirmation. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Closure of Trading Window
Please find attached herewith the Intimation of Closure of Trading Window. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached herewith, the intimation dated 21st March, 2024 received from our RTA. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
We would like to inform the exchange that the Company has received an Order from Commissioner of Customs (Appeals) Mumbai imposing Penalty. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached herewith, the intimation dated 18th March, 2024 received from our RTA.